Laura Cosmai

1.7k total citations
56 papers, 997 citations indexed

About

Laura Cosmai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Laura Cosmai has authored 56 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Laura Cosmai's work include Renal cell carcinoma treatment (28 papers), Renal and related cancers (9 papers) and Chemotherapy-induced organ toxicity mitigation (9 papers). Laura Cosmai is often cited by papers focused on Renal cell carcinoma treatment (28 papers), Renal and related cancers (9 papers) and Chemotherapy-induced organ toxicity mitigation (9 papers). Laura Cosmai collaborates with scholars based in Italy, United States and France. Laura Cosmai's co-authors include Camillo Porta, Maurizio Gallieni, Francesco Massari, Mimma Rizzo, Paolo Pedrazzoli, Fabio Malberti, Veronica Mollica, Mark A. Perazella, Matteo Santoni and Axel Bex and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Laura Cosmai

49 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Cosmai Italy 21 514 325 276 234 158 56 997
Hideki Ishida Japan 18 471 0.9× 216 0.7× 259 0.9× 303 1.3× 393 2.5× 120 1.1k
Elisabeth Jones United States 5 309 0.6× 206 0.6× 280 1.0× 318 1.4× 161 1.0× 5 1.0k
Zheng Tang China 16 239 0.5× 178 0.5× 125 0.5× 264 1.1× 135 0.9× 51 796
Thomas Robert France 15 140 0.3× 478 1.5× 243 0.9× 345 1.5× 108 0.7× 59 1.1k
Koki Mise Japan 20 212 0.4× 301 0.9× 100 0.4× 567 2.4× 163 1.0× 83 1.2k
Masaharu Nishikido Japan 18 403 0.8× 337 1.0× 266 1.0× 51 0.2× 326 2.1× 58 1.0k
Elisa Menegatti Italy 21 223 0.4× 260 0.8× 104 0.4× 272 1.2× 107 0.7× 76 1.3k
Sunjay Jain United Kingdom 19 357 0.7× 421 1.3× 530 1.9× 85 0.4× 720 4.6× 62 1.6k
Sergio Siragusa Italy 26 195 0.4× 360 1.1× 242 0.9× 64 0.3× 360 2.3× 150 2.1k
Massimo Iacobelli United States 19 102 0.2× 347 1.1× 272 1.0× 176 0.8× 224 1.4× 54 1.9k

Countries citing papers authored by Laura Cosmai

Since Specialization
Citations

This map shows the geographic impact of Laura Cosmai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cosmai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cosmai more than expected).

Fields of papers citing papers by Laura Cosmai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cosmai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cosmai. The network helps show where Laura Cosmai may publish in the future.

Co-authorship network of co-authors of Laura Cosmai

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cosmai. A scholar is included among the top collaborators of Laura Cosmai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cosmai. Laura Cosmai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirovano, Marta, et al.. (2024). Osimertinib in a patient with end-stage kidney disease not on hemodialysis. Journal of Nephrology. 38(1). 275–278.
2.
Tucci, Marcello, Laura Cosmai, Marta Pirovano, et al.. (2024). How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists. Cancer Treatment Reviews. 125. 102692–102692. 2 indexed citations
3.
Pirovano, Marta, et al.. (2024). Acute Kidney Injury Associated with Anticancer Therapies: Small Molecules and Targeted Therapies. SHILAP Revista de lepidopterología. 5(11). 1750–1762.
4.
Pirovano, Marta, Carlo Ganini, Maurizio Gallieni, Camillo Porta, & Laura Cosmai. (2024). Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology. Journal of Nephrology. 38(5). 1369–1379.
5.
Cavalieri, Stefano, Francesca Platini, Francesco Barretta, et al.. (2023). Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience. Oral Oncology. 146. 106579–106579. 4 indexed citations
6.
Stewart, Grant D., Tobias Klatte, Laura Cosmai, et al.. (2022). The multispeciality approach to the management of localised kidney cancer. The Lancet. 400(10351). 523–534. 25 indexed citations
7.
Pirovano, Marta & Laura Cosmai. (2022). Nephrological management of renal cell carcinoma (RCC) patients: A narrative review. 6(3). 97–106. 1 indexed citations
8.
9.
Cosmai, Laura, et al.. (2021). Acute Proteinuric Renal Failure in a Lung Cancer Patient Treated with Poziotinib: First Case Described in the Literature. Journal of the American Society of Nephrology. 32(10S). 579–579.
10.
Fusaro, Maria, Laura Cosmai, Pieter Evenepoel, et al.. (2020). Vitamin K and Kidney Transplantation. Nutrients. 12(9). 2717–2717. 7 indexed citations
11.
Massari, Francesco, Veronica Mollica, Alessandro Rizzo, et al.. (2020). Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis. Expert Opinion on Drug Safety. 19(10). 1329–1338. 67 indexed citations
12.
Santoni, Matteo, Alessia Cimadamore, Matteo Giulietti, et al.. (2020). Exploring the Spectrum of Kidney Ciliopathies. Diagnostics. 10(12). 1099–1099. 12 indexed citations
13.
Ronco, Federico, Lorenzo Azzalini, Carlo Briguori, et al.. (2019). Documento di consenso SICI-GISE/SIN: Danno renale acuto da mezzo di contrasto in cardiologia interventistica. Giornale italiano di cardiologia. 20(9). 29–43. 1 indexed citations
14.
Ronco, Federico, Lorenzo Azzalini, Carlo Briguori, et al.. (2019). [SICI-GISE/SIN Consensus document: Contrast-induced acute kidney injury in interventional cardiology].. PubMed. 20(9 Suppl 1). 29S–43S. 1 indexed citations
15.
Vitale, Maria Giuseppa, Cinzia Baldessari, Michèle Milella, et al.. (2019). Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature. Clinical Genitourinary Cancer. 17(5). e903–e908. 25 indexed citations
16.
Gallieni, Maurizio, Laura Cosmai, & Camillo Porta. (2018). Acute Kidney Injury in Cancer Patients. Contributions to nephrology. 193. 137–148. 20 indexed citations
17.
Pani, Antonello, Camillo Porta, Laura Cosmai, et al.. (2015). Glomerular diseases and cancer: evaluation of underlying malignancy. Journal of Nephrology. 29(2). 143–152. 54 indexed citations
18.
Frascà, Giovanni M., Silvio Sandrini, Laura Cosmai, et al.. (2015). Renal cancer in kidney transplanted patients. Journal of Nephrology. 28(6). 659–668. 33 indexed citations
19.
Masini, Cristina, Roberto Sabbatini, Camillo Porta, et al.. (2012). Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey. British Journal of Urology. 110(5). 692–698. 36 indexed citations
20.
Graziani, G., et al.. (2010). Gitelman syndrome: pathophysiological and clinical aspects. QJM. 103(10). 741–748. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026